1GA
ARRY

1st Global Advisors’s Array Biopharma Inc ARRY Stock Holding History

1st Global Advisors’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		$86K Sell
10,271
-32
-0.3% -$262 0.01% 503
2017
Q1 		$92K Buy
10,303
+160
+2% +$1.7K 0.01% 501
2016
Q4 		$89K Buy
+10,143
New +$74.6K 0.01% 511

Other funds holding ARRY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

1st Global Advisors's ARRY Position: Q2 2017 in Review

1st Global Advisors reduced its Array Biopharma Inc (ARRY) stake by 0.31% in Q2 2017, selling an estimated $262 and leaving 10,271 shares worth $86K. The position accounts for 0.01% of the portfolio, ranked #503.

1st Global Advisors first reported a position in ARRY in Q4 2016 and has held it in 3 quarters since. The position peaked at $92K in Q1 2017. 182 funds tracked by Wall St. Rank hold ARRY as of Q2 2017.

  • 1st Global Advisors held 10,271 shares of Array Biopharma Inc worth $86K as of Q2 2017.
  • 1st Global Advisors sold 32 Array Biopharma Inc shares in Q2 2017, an estimated $262.
  • Array Biopharma Inc made up 0.01% of 1st Global Advisors's portfolio in Q2 2017, its #503 holding.
  • 1st Global Advisors first reported a position in Array Biopharma Inc in Q4 2016 and has held it in 3 quarters since.
  • 1st Global Advisors's Array Biopharma Inc position peaked at $92K in Q1 2017.
  • 182 funds tracked by Wall St. Rank held Array Biopharma Inc as of Q2 2017.

Based on 1st Global Advisors's 13F filing for Q2 2017, filed 15 Aug 2017.